Kelly S. Levano
- Co-authors
- Paraic A. KennyHeinner GuioDavid TarazonaEric H. JungCésar SánchezMarco GalarzaProbal BanerjeeSudarshana Purkayastha
- Topics
- Tuberculosis Research and Epidemiology (6 papers)Drug-Induced Hepatotoxicity and Protection (4 papers)Pharmacogenetics and Drug Metabolism (4 papers)
- Cited by
- PharmacologyGeneticsOncology
- Journals
- Proceedings of the National Academy of SciencesBrain ResearchBiochemical and Biophysical Research Communications
- Partner nations
- PeruUnited StatesBrazil
In The Last Decade
Kelly S. Levano
20 papers receiving 305 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 128
- Genetics 77
- Oncology 68
- Infectious Diseases 39
- Immunology 38
Countries citing papers authored by Kelly S. Levano
This map shows the geographic impact of Kelly S. Levano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly S. Levano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly S. Levano more than expected).
Fields of papers citing papers by Kelly S. Levano
This network shows the impact of papers produced by Kelly S. Levano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly S. Levano. The network helps show where Kelly S. Levano may publish in the future.
Co-authorship network of co-authors of Kelly S. Levano
This figure shows the co-authorship network connecting the top 25 collaborators of Kelly S. Levano. A scholar is included among the top collaborators of Kelly S. Levano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly S. Levano. Kelly S. Levano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 10 | |
| 4 | 3 | |
| 5 | 10 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 85 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 13 | |
| 13 | 23 | |
| 14 | 5 | |
| 15 | 6 | |
| 16 | 14 | |
| 17 | 31 | |
| 18 | 57 | |
| 19 | 17 | |
| 20 | 3 |
About Kelly S. Levano
Kelly S. Levano is a scholar working on Pharmacology, Infectious Diseases and Oncology, having authored 21 papers that have together received 309 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Pharmacology (31 citations), Genetics (77 citations) and Oncology (68 citations). Kelly S. Levano has collaborated with scholars based in Peru, United States and Brazil. Frequent co-authors include Paraic A. Kenny, Heinner Guio, David Tarazona, Eric H. Jung, César Sánchez, Marco Galarza, Probal Banerjee, Sudarshana Purkayastha, Daniel P. McCloskey and Michael Raghunath. Their work appears in journals such as Proceedings of the National Academy of Sciences, Brain Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.